SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : NanoViricides - Nanobiotechnology
NNVC 7.520+2.6%May 29 4:00 PM EDT

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: donpat2/11/2019 9:28:05 AM
of 1214
 
High aspirations for a 40¢ stock!

I'm looking for $40 realistically when achieved.

"The Company anticipates achieving several additional important milestones in the current calendar year, now that we have successfully met the milestones of declaring our first clinical candidate and initiating IND-enabling Safety/Tox Package studies for the same. In brief, these include achieving successful cGMP-like production of the drug as required for the "Tox Package" studies and improving the same for further human clinical product batches, completion of the Tox Package studies, a "Pre-IND" meeting with the FDA, filing of an IND, and the beginning of initial human clinical trials."


marketwatch.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext